Novartis

News

Lilly chases Amgen with migraine drug filing

Eli Lilly has filed its galcanezumab migraine drug with the FDA, as it looks to claim second place among a group of companies attempting to market a new class of therapies.

News

Long-term CAR-T data dazzles at ASH

Gilead and Novartis CAR-Ts steal the show at ASH

News

Gilead goes full throttle on CAR-Ts with $567m acquisition

Gilead hopes CDL technology will create therapies targeting solid tumours

News

NICE recommends Eisai's kidney cancer combination

NICE has recommended Eisai’s Kisplyx (lenvatinib) in combination with Novartis’ Afinitor (everolimus) in kidney cancer after the company further dropped its price.

News